IGF signaling defects as causes of growth failure and IUGR

[1]  T. Yagi,et al.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.

[2]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[3]  M. Savage,et al.  Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.

[4]  R. Kucherlapati,et al.  K-ras is an essential gene in the mouse with partial functional overlap with N-ras. , 1997, Genes & development.

[5]  Stefano Fumagalli,et al.  Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase , 1998, The EMBO journal.

[6]  Tony Pawson,et al.  Mammalian Grb2 Regulates Multiple Steps in Embryonic Development and Malignant Transformation , 1998, Cell.

[7]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[8]  J. Charron,et al.  Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta , 1999, Current Biology.

[9]  M. White,et al.  Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling , 1999, Nature Genetics.

[10]  J. Pouysségur,et al.  Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. , 1999, Science.

[11]  Y. Matsuzawa,et al.  Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase , 1999, Nature Genetics.

[12]  R. Nussbaum,et al.  Proliferative Defect and Embryonic Lethality in Mice Homozygous for a Deletion in the p110α Subunit of Phosphoinositide 3-Kinase* , 1999, The Journal of Biological Chemistry.

[13]  Daniel A. Pollard,et al.  Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85α , 2000, Nature Genetics.

[14]  T Pawson,et al.  The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. , 2000, Genes & development.

[15]  M. White,et al.  [Letters to nature] , 1975, Nature.

[16]  S. Aizawa,et al.  Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.

[17]  Y. Azuma,et al.  Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. , 2000, The Journal of clinical investigation.

[18]  D. Lowy,et al.  The Sos1 and Sos2 Ras‐specific exchange factors: differences in placental expression and signaling properties , 2000, The EMBO journal.

[19]  M. Holzenberger,et al.  A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit. , 2000, Endocrinology.

[20]  R. Burcelin,et al.  Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.

[21]  G. Shulman,et al.  Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. , 2001, Genes & development.

[22]  E. Wagner,et al.  Embryonic lethality and fetal liver apoptosis in mice lacking the c‐raf‐1 gene , 2001, The EMBO journal.

[23]  Kohjiro Ueki,et al.  Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Kaestner,et al.  Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .

[25]  M. Malumbres,et al.  Targeted Genomic Disruption of H-ras and N-ras, Individually or in Combination, Reveals the Dispensability of Both Loci for Mouse Growth and Development , 2001, Molecular and Cellular Biology.

[26]  I. Roninson,et al.  Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. , 2001, Genes & development.

[27]  M. Birnbaum,et al.  Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice* , 2001, The Journal of Biological Chemistry.

[28]  T. Frayling,et al.  Conflicting results on variation in the IGFI gene highlight methodological considerations in the design of genetic association studies , 2002, Diabetologia.

[29]  Albert Hofman,et al.  Association between genetic variation in the gene for insulin-like growth factor-l and low birthweight , 2002, The Lancet.

[30]  K. Okkenhaug,et al.  Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.

[31]  M. Stoffel,et al.  β-cell–specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass , 2002, Nature Genetics.

[32]  M. Tally,et al.  Transforming Growth Factor‐β1 in Fetal Serum Correlates With Insulin‐like Growth Factor‐I and Fetal Growth , 2002 .

[33]  A. Prescott,et al.  Essential role of PDK1 in regulating cell size and development in mice , 2002, The EMBO journal.

[34]  M. Tremblay,et al.  Mek2 Is Dispensable for Mouse Growth and Development , 2003, Molecular and Cellular Biology.

[35]  S. Meloche,et al.  An essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development , 2003, EMBO reports.

[36]  Martin Holzenberger,et al.  IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.

[37]  P. Strisciuglio,et al.  A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency , 2003, Journal of medical genetics.

[38]  J. Dupont,et al.  Biology of insulin-like growth factors in development. , 2003, Birth defects research. Part C, Embryo today : reviews.

[39]  C. Lautier,et al.  IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. , 2003, The New England journal of medicine.

[40]  J. Stock,et al.  Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. , 2003, The Journal of clinical investigation.

[41]  A. Fowden.  The insulin-like growth factors and feto-placental growth. , 2003, Placenta.

[42]  Brian A. Hemmings,et al.  Protein Kinase Bα/Akt1 Regulates Placental Development and Fetal Growth* , 2003, Journal of Biological Chemistry.

[43]  D. Alessi,et al.  Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia , 2003, The EMBO journal.

[44]  Wayne A. Phillips,et al.  Mutation of the PIK3CA Gene in Ovarian and Breast Cancer , 2004, Cancer Research.

[45]  Hiroyuki Konishi,et al.  The PIK3CA gene is mutated with high frequency in human breast cancers , 2004, Cancer biology & therapy.

[46]  B. Manning.  Balancing Akt with S6K , 2004, The Journal of cell biology.

[47]  Johan Auwerx,et al.  Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.

[48]  Mark A. Hanson,et al.  The developmental origins of the metabolic syndrome , 2004, Trends in Endocrinology & Metabolism.

[49]  Stefano Fumagalli,et al.  S6K1−/−/S6K2−/− Mice Exhibit Perinatal Lethality and Rapamycin-Sensitive 5′-Terminal Oligopyrimidine mRNA Translation and Reveal a Mitogen-Activated Protein Kinase-Dependent S6 Kinase Pathway , 2004, Molecular and Cellular Biology.

[50]  C. Kahn,et al.  p50α/p55α Phosphoinositide 3-Kinase Knockout Mice Exhibit Enhanced Insulin Sensitivity , 2004, Molecular and Cellular Biology.

[51]  Kozo Nakamura,et al.  Deficiency of Insulin Receptor Substrate‐1 Impairs Skeletal Growth Through Early Closure of Epiphyseal Cartilage , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  Simeon I. Taylor,et al.  Clinical Course of Genetic Diseases of the Insulin Receptor (Type A and Rabson-Mendenhall Syndromes): A 30-Year Prospective , 2004, Medicine.

[53]  D. Alessi,et al.  The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development , 2004, Nature Immunology.

[54]  Howard L McLeod,et al.  PI3K/Akt/mTOR pathway as a target for cancer therapy , 2005, Anti-cancer drugs.

[55]  I. Hisatome,et al.  Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. , 2005, The Journal of clinical endocrinology and metabolism.

[56]  F. Tronche,et al.  Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure. , 2005, The Biochemical journal.

[57]  Jeroen J. Bax,et al.  Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. , 2005, The Journal of clinical endocrinology and metabolism.

[58]  Yuval Dor,et al.  Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. , 2005, Genes & development.

[59]  C. Taniguchi,et al.  Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. , 2005, The Journal of clinical investigation.

[60]  J. Frahm,et al.  Essential role of protein kinase Bγ (PKBγ/Akt3) in postnatal brain development but not in glucose homeostasis , 2005, Development.

[61]  R. Giorgino,et al.  Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. , 2005, Endocrinology.

[62]  T. Ludwig,et al.  Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size , 2005, Molecular and Cellular Biology.

[63]  Y. Le Marchand-Brustel,et al.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. , 2005, Biochimie.

[64]  F. Artunc,et al.  Impaired intestinal NHE3 activity in the PDK1 hypomorphic mouse. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[65]  P. Gluckman,et al.  The Consequences of Being Born Small – An Adaptive Perspective , 2006, Hormone Research in Paediatrics.

[66]  H. Werner,et al.  The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action , 2006, Trends in Endocrinology & Metabolism.

[67]  S. Ozanne,et al.  Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome , 2006, Physiology & Behavior.

[68]  J. Kratzsch,et al.  Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R. , 2006, The Journal of clinical endocrinology and metabolism.

[69]  K. Ong.  Size at Birth, Postnatal Growth and Risk of Obesity , 2006, Hormone Research in Paediatrics.

[70]  J. Romijn,et al.  A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. , 2006, The Journal of clinical endocrinology and metabolism.

[71]  P. Backeljauw,et al.  Treatment of Insulin-Like Growth Factor Deficiency with IGF-I: Studies in Humans , 2006, Hormone Research in Paediatrics.

[72]  Roger Smith,et al.  Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. , 2006, Endocrine reviews.

[73]  Y. Kido,et al.  Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass , 2006, Nature Genetics.

[74]  J. Wit,et al.  Genetic Disorders in the Growth Hormone – Insulin-Like Growth Factor-I Axis , 2006, Hormone Research in Paediatrics.

[75]  R. Memmott,et al.  Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway , 2006, Clinical Cancer Research.

[76]  Yuki Kawashima,et al.  OR11-5 A FAMILY WITH SHORT STATURE BORN INTRAUTERINE GROWTH RETARDATION BEARING A NEW MISSENSE MUTATION AT α SUBUNIT OF IGF-I RECEPTOR (R431L) , 2006 .

[77]  D. Leroith,et al.  A familial insulin-like growth factor-I receptor mutant leads to short stature: clinical and biochemical characterization. , 2007, The Journal of clinical endocrinology and metabolism.

[78]  V. Hwa,et al.  Defects in growth hormone receptor signaling , 2007, Trends in Endocrinology & Metabolism.

[79]  T. Powell,et al.  Mammalian target of rapamycin in the human placenta regulates leucine transport and is down‐regulated in restricted fetal growth , 2007, The Journal of physiology.

[80]  E. Reiter.  Hormonal Treatment of Idiopathic Short Stature , 2007, Hormone Research in Paediatrics.

[81]  P. Czernichow,et al.  Small for gestational age: short stature and beyond. , 2007, Endocrine reviews.

[82]  F. Giorgino,et al.  The IGF-I signaling pathway. , 2007, Current pharmaceutical design.

[83]  Tom R. Gaunt,et al.  Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease , 2007, Human Genetics.

[84]  R. Nussbaum,et al.  Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase , 2002, Mammalian Genome.

[85]  Spyro Mousses,et al.  A transforming mutation in the pleckstrin homology domain of AKT1 in cancer , 2007, Nature.

[86]  B. Hallgrímsson,et al.  Inactivation of Pten in Osteo‐Chondroprogenitor Cells Leads to Epiphyseal Growth Plate Abnormalities and Skeletal Overgrowth , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.